AF
MIRM icon

Amalgamated Financial’s Mirum Pharmaceuticals MIRM Stock Holding History

Amalgamated Financial’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$11K Buy
+516
New +$10.5K ﹤0.01% 2879

Other funds holding MIRM

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
RVM
RiverVest Venture Management St. Louis, Missouri $6.84M AUM 7.71% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Amalgamated Financial's MIRM Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Mirum Pharmaceuticals (MIRM) in Q1 2022: 516 shares worth $11K. The stake represents ﹤0.01% of the portfolio and ranks #2879 among its holdings.

99 funds tracked by Wall St. Rank hold MIRM as of Q1 2022.

  • Amalgamated Financial held 516 shares of Mirum Pharmaceuticals worth $11K as of Q1 2022.
  • Mirum Pharmaceuticals was a new Amalgamated Financial position in Q1 2022.
  • Mirum Pharmaceuticals made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #2879 holding.
  • 99 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.